EUVIMEDEUVIMED entdecken
Crossref

Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine

Ryo Sato, Kenya Terabe iD, Takahiro Imaizumi, Koji Sakamoto iD, Kikue Sato, Junya Hasegawa iD, Takaya Sugiura, Yusuke Ono, Mochihito Suzuki iD, Shuji Asai, Shiro Imagama

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Ryo Sato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Aichi, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Pneumonia, Pneumocystis, Antirheumatic Agents, Sulfasalazine. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to assess the risk factors for Pneumocystis pneumonia (PCP) in patients with rheumatoid arthritis (RA) and investigate the potential of salazosulfapyridine (SASP) as a prophylactic agent.

Methods

The present study analyzed data from the Japanese Diagnosis Procedure Combination database, which provides comprehensive inpatient data (including diagnoses, procedures, and medications) covering a large portion of the population. We identified patients with RA who developed PCP among 14 190 patients diagnosed with RA at admission with a treatment history. Patients with RA who were receiving therapeutic doses of drugs for PCP were defined as having PCP. A nested case–control analysis was performed to compare patients with RA and PCP with age‐ and sex‐matched control patients with RA without PCP in a ratio of 1:20.

Results

The cohort comprised 132 patients with PCP and 2575 controls. The risk factors for PCP in RA were chronic obstructive pulmonary disease, methotrexate (MTX), biological/targeted synthetic DMARDs (b/tsDMARDs), and high‐dose glucocorticoids. SASP may have a protective effect against PCP, particularly in patients with RA treated with MTX and/or b/tsDMARDs.

Conclusion

The large sample size of the present study suggests that SASP may be associated with a reduced PCP risk in RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidPneumonia, PneumocystisAntirheumatic AgentsSulfasalazineOpportunistic InfectionsHumansRisk FactorsMaleFemaleMiddle AgedAgedCase-Control StudiesJapanDatabases, FactualRisk AssessmentTreatment OutcomeImmunocompromised HostAdultMethotrexateProtective FactorsOdds RatioGlucocorticoidsRetrospective Studies

Stichwörter der Autor:innen

antirheumatic agentsglucocorticoidsmethotrexatepneumocystis pneumoniarheumatoid arthritissalazosulfapyridine

Substanzen

Antirheumatic AgentsSulfasalazineMethotrexateGlucocorticoids

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
  • Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Medical IT Center, Nagoya University Hospital, Aichi, Japan.

ORCID-Profile: Kenya Terabe, Koji Sakamoto, Junya Hasegawa, Mochihito Suzuki

Zitieren

APA

Sato, R., Terabe, K., Imaizumi, T., Sakamoto, K., Sato, K., Hasegawa, J., Sugiura, T., Ono, Y., Suzuki, M., Asai, S., & Imagama, S. (2025). Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70516

Vancouver

Sato R, Terabe K, Imaizumi T, Sakamoto K, Sato K, Hasegawa J, et al. Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70516

BibTeX
@article{Sato2025,
  author = {Sato, Ryo and Terabe, Kenya and Imaizumi, Takahiro and Sakamoto, Koji and Sato, Kikue and Hasegawa, Junya and Sugiura, Takaya and Ono, Yusuke and Suzuki, Mochihito and Asai, Shuji and Imagama, Shiro},
  title = {Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70516}
}
Kostenlos starten →